The global Oxygen Therapy Market size was valued at USD 33.82 billion in 2023 and is projected to reach USD 61.08 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.79% over the forecast period from 2024 to 2032. Market expansion is being fueled by the growing burden of chronic respiratory diseases, increasing preference for home-based care, and continuous innovation in portable and smart oxygen delivery systems.
The demand for oxygen therapy solutions has accelerated significantly following the COVID-19 pandemic, which reshaped healthcare delivery models worldwide. Hospitals and care providers increasingly adopted home-based oxygen therapy services to reduce inpatient burden while ensuring continuous care for respiratory patients. This shift has driven strong demand for oxygen concentrators, cylinders, and related delivery devices designed specifically for in-home applications, offering patients greater comfort, convenience, and safety.
Get free Sample Report@ https://www.snsinsider.com/sample-request/4447
The growing availability of portable and user-friendly oxygen therapy devices has further supported adoption, particularly in developed regions with advanced healthcare infrastructure. Favorable reimbursement frameworks have also played a critical role. In the United States, the Centers for Medicare & Medicaid Services (CMS) expanded coverage for home oxygen therapy equipment in 2020, enabling broader patient access to essential respiratory care and significantly contributing to market growth across North America.
Technological Innovation and Early Diagnosis Awareness Strengthen Market Outlook
Another major growth catalyst is the rising awareness of early diagnosis and timely treatment of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma. Public health campaigns and improved access to advanced diagnostic tools—including pulmonary function testing and imaging technologies—have enhanced clinicians’ ability to identify respiratory conditions at earlier stages. This has directly increased the demand for long-term oxygen therapy solutions.
Product innovation remains a key competitive strategy among leading manufacturers. In 2023, Invacare launched the Platinum Mobile Oxygen Concentrator, featuring enhanced portability and extended battery life to meet the growing need for mobile respiratory care. Similarly, the development of smart oxygen therapy devices with real-time monitoring capabilities has improved patient compliance, mobility, and overall treatment outcomes, driving higher adoption rates globally.
Market Drivers: Strengthened Global Efforts to Combat Respiratory Diseases
The oxygen therapy market is strongly supported by intensified efforts from governments and healthcare organizations to address respiratory illnesses—among the leading causes of mortality worldwide. According to the World Health Organization (WHO), chronic respiratory diseases accounted for nearly 7% of global deaths in 2022. In response, healthcare funding and policy initiatives have expanded significantly.
For example, in 2023, the U.S. Department of Health and Human Services allocated over USD 4 billion to improve respiratory care services. Concurrently, industry players continue to expand their product portfolios. Philips introduced a new range of portable oxygen concentrators in 2023, aligning with the rising demand for at-home respiratory care solutions. These combined public and private sector initiatives are creating a strong foundation for long-term market growth.
Market Restraints: High Equipment and Treatment Costs
Despite its essential role in managing chronic respiratory conditions, the oxygen therapy market faces challenges related to high equipment and maintenance costs. Oxygen concentrators, liquid oxygen systems, and compressed gas cylinders can impose significant financial burdens, particularly in regions with limited insurance coverage. In some markets, including the United States, Medicare reimbursement limitations result in higher out-of-pocket expenses for patients requiring continuous oxygen therapy, potentially restraining adoption rates.
Oxygen Therapy Market Segmentation Insights
By product, oxygen source equipment accounted for 62.44% of the market share in 2023, driven by widespread use of oxygen concentrators, cylinders, and liquid oxygen systems. Oxygen concentrators are expected to witness the fastest growth due to increasing demand for energy-efficient and reliable solutions. In May 2023, Drive DeVilbiss Healthcare launched the 1060AW 10-liter oxygen concentrator, widely adopted in rural and semi-urban healthcare settings.
By application, the COPD segment held the largest market share in 2023, supported by the rising global COPD patient population. According to the American Lung Association, 11.7 million U.S. adults were diagnosed with COPD in 2022, underscoring the growing clinical need for oxygen therapy.
By end-use, home healthcare dominated the market with a 68.65% share, reflecting patient preference for long-term, cost-effective, and comfortable at-home treatment options—especially among the elderly population.
Regional Analysis: North America Leads the Global Market
North America accounted for 35.21% of the global oxygen therapy market share in 2023, supported by advanced healthcare infrastructure, strong reimbursement systems, and high prevalence of respiratory diseases. The American Lung Association reports that over 16 million Americans have been diagnosed with COPD, driving sustained demand for oxygen therapy products across the region.
Key Players and Recent Developments
Major market participants include ResMed, Inogen, Fisher & Paykel Healthcare, Teleflex, Chart Industries, OMRON Healthcare, and others. Recent innovations highlight strong industry momentum. In 2024, Brezan Technologies launched the Brezan 360 home oxygen system, integrating AI-driven oxygen optimization and real-time patient monitoring. In 2023, Philips introduced the EverFlo Q portable oxygen concentrator, while ResMed launched the AirSense 11 CPAP machine with advanced oxygen therapy integration.
Other Trending Reports
Microdermabrasion Devices Market
Pharmacovigilance and Drug Safety Software Market Growth
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Rohan Jadhav – Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
